XML 1077 R50.htm IDEA: XBRL DOCUMENT v3.8.0.1
Equity (Tables)
 12 Months Ended
Dec. 31, 2017
Class of Stock [Line Items]  
Schedule of Stock by Class [Table Text Block]
Preferred stock authorized, issued and outstanding was as follows at both December 31, 2017 and 2016:
Series

Shares
Authorized

Shares
Issued

Shares
Outstanding
Floating Rate Non-Cumulative Preferred Stock, Series A

27,600,000

 
24,000,000

 
24,000,000

5.25% Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series C

1,500,000

 
1,500,000

 
1,500,000

Series A Junior Participating Preferred Stock

10,000,000

 
—

 
—

Not designated

160,900,000

 
—

 
—

Total

200,000,000


25,500,000


25,500,000
Schedule of Dividends Paid, Preferred Stock
The declaration, record and payment dates, as well as per share and aggregate dividend amounts, for the Series A, Series B and Series C preferred stock was as follows:
 
 
 
 
 
 
Dividend
Declaration Date
 
Record Date
 
Payment Date
 
Series A
Per Share
 
Series A
Aggregate
 
Series B
Per Share
 
Series B
Aggregate
 
Series C
Per Share
 
Series C
Aggregate
 
 
 
 
 
 
(In millions, except per share data)
November 15, 2017
 
November 30, 2017
 
December 15, 2017
 
$
0.253

 
$
6

 
$
—

 
$
—

 
$
26.250

 
$
39

August 15, 2017
 
August 31, 2017
 
September 15, 2017
 
$
0.256

 
6

 
$
—

 
—

 
$
—

 
—

May 15, 2017
 
May 31, 2017
 
June 15, 2017
 
$
0.256

 
7

 
$
—

 
—

 
$
26.250

 
39

March 6, 2017
 
February 28, 2017
 
March 15, 2017
 
$
0.250

 
6

 
$
—

 
—

 
$
—

 
—

 
 
 
 
 
 
 
 
$
25

 
 
 
$
—

 
 
 
$
78

November 15, 2016
 
November 30, 2016
 
December 15, 2016
 
$
0.253

 
$
6

 
$
—

 
$
—

 
$
26.250

 
$
39

August 15, 2016
 
August 31, 2016
 
September 15, 2016
 
$
0.256

 
6

 
$
—

 
—

 
$
—

 
—

May 16, 2016
 
May 31, 2016
 
June 15, 2016
 
$
0.256

 
7

 
$
—

 
—

 
$
26.250

 
39

March 7, 2016
 
February 29, 2016
 
March 15, 2016
 
$
0.253

 
6

 
$
—

 
—

 
$
—

 
—

 
 
 
 
 
 
 
 
$
25

 
 
 
$
—

 
 
 
$
78

November 16, 2015
 
November 30, 2015
 
December 15, 2015
 
$
0.253

 
$
6

 
$
—

 
$
—

 
$
28.292

 
$
43

August 17, 2015
 
August 31, 2015
 
September 15, 2015
 
$
0.256

 
6

 
$
—

 
—

 
$
—

 
—

May 15, 2015
 
May 31, 2015
 
June 15, 2015
 
$
0.256

 
7

 
$
0.406

 
24

 
$
—

 
—

March 5, 2015
 
February 28, 2015
 
March 16, 2015
 
$
0.250

 
6

 
$
0.406

 
24

 
$
—

 
—

 
 
 
 
 
 
 
 
$
25

 
 
 
$
48

 
 
 
$
43
Schedule of Dividends Paid, Common Stock
The declaration, record and payment dates, as well as per share and aggregate dividend amounts, for common stock was as follows:
 
 
 
 
 
 
Dividend
Declaration Date
 
 Record Date
 
 Payment Date
 
Per Share
 
Aggregate
 
 
 
 
 
 
(In millions, except per share data)
October 24, 2017
 
November 6, 2017
 
December 13, 2017
 
$
0.400

 
$
422

July 7, 2017
 
August 7, 2017
 
September 13, 2017
 
$
0.400

 
427

April 25, 2017
 
May 8, 2017
 
June 13, 2017
 
$
0.400

 
431

January 6, 2017
 
February 6, 2017
 
March 13, 2017
 
$
0.400

 
437

 
 
 
 
 
 
 
 
$
1,717

October 25, 2016
 
November 7, 2016
 
December 13, 2016
 
$
0.400

 
$
441

July 7, 2016
 
August 8, 2016
 
September 13, 2016
 
$
0.400

 
441

April 26, 2016
 
May 9, 2016
 
June 13, 2016
 
$
0.400

 
441

January 6, 2016
 
February 5, 2016
 
March 14, 2016
 
$
0.375

 
413

 
 
 
 
 
 
 
 
$
1,736

October 27, 2015
 
November 6, 2015
 
December 11, 2015
 
$
0.375

 
$
419

July 7, 2015
 
August 7, 2015
 
September 11, 2015
 
$
0.375

 
420

April 28, 2015
 
May 11, 2015
 
June 12, 2015
 
$
0.375

 
420

January 6, 2015
 
February 6, 2015
 
March 13, 2015
 
$
0.350

 
394

 
 
 
 
 
 
 
 
$
1,653
Components of compensation expense related to stock based compensation
The components of compensation expense related to stock-based compensation includes compensation expense related to Phantom Stock-Based Awards, and excludes the insignificant compensation expense related to the 2015 Director Stock Plan. Those components were:
 
Years Ended December 31,
 
2017
 
2016
 
2015
 
(In millions)
Stock Options and Unit Options
$
8

 
$
9

 
$
12

Performance Shares and Performance Units (1)
62

 
75

 
59

Restricted Stock Units and Restricted Units
58

 
63

 
66

Total compensation expense
$
128

 
$
147

 
$
137

Income tax benefit
$
45

 
$
51

 
$
48

__________________
(1)
Performance Shares expected to vest and the related compensation expenses may be further adjusted by the performance factor most likely to be achieved, as estimated by management, at the end of the performance period.
Total unrecognized compensation expense related to stock based compensation and the expected weighted average period over which the expenses will be recognized
The following table presents the total unrecognized compensation expense related to stock-based compensation and the expected weighted average period over which these expenses will be recognized at:
 
December 31, 2017
 
Expense
 
Weighted Average
Period
 
(In millions)
 
(Years)
Stock Options
$
4

 
1.77
Performance Shares
$
30

 
1.59
Restricted Stock Units
$
40

 
1.84
Activity related to Stock Options
The following table presents a summary of Stock Option exercise activity:
 
 
Years Ended December 31,
 
 
2017
 
2016
 
2015
 
 
(In millions)
Total intrinsic value of stock options exercised
 
$
59

 
$
42

 
$
44

Cash received from exercise of stock options
 
$
116

 
$
84

 
$
121

Income tax benefit realized from stock options exercised
 
$
20

 
$
15

 
$
15

A summary of the activity related to Stock Options was as follows:
 
Shares
Under
Option
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Contractual
Term
 
Aggregate
Intrinsic
Value (1)
 
 
 
 
 
(Years)
 
(In millions)
Outstanding at January 1, 2017
19,482,388

 
$
44.73

 
3.68
 
$
218

Granted (2)
709,085

 
$
46.85

 
 
 
 
Exercised (2)
(3,475,198
)
 
$
33.36

 
 
 
 
Expired (2)
(2,913,457
)
 
$
56.06

 
 
 
 
Forfeited (2)
(115,670
)
 
$
40.06

 
 
 
 
Other Separation adjustment (2)
2,322,606

 
$
38.40

 
 
 
 
Outstanding at December 31, 2017
16,009,754

 
$
38.77

 
3.54
 
$
198

Vested and expected to vest at December 31, 2017
15,991,119

 
$
38.76

 
3.13
 
$
238

Exercisable at December 31, 2017
14,487,455

 
$
38.46

 
3.02
 
$
185

__________________
(1)
The intrinsic value of each Stock Option is the closing price on a particular date less the exercise price of the Stock Option, so long as the difference is greater than zero. The aggregate intrinsic value of all outstanding Stock Options is computed using the closing Share price on December 31, 2017 of $50.56 and December 31, 2016 of $48.02, as applicable.
(2)
For Stock Options outstanding as of August 4, 2017, MetLife, Inc. increased the number of Stock Options by an adjustment ratio, and lowered their exercise price by dividing it by the same adjustment ratio, to maintain the intrinsic value of the award pursuant to the anti-dilution provisions of the 2015 Stock Plan and the 2005 Stock Plan as a result of the Separation. MetLife, Inc. determined the adjustment ratio by dividing the $53.92 closing price of MetLife, Inc. common stock on August 4, 2017 by the $48.17 opening price of MetLife, Inc. common stock on August 7, 2017, the next trading day. Each of “Granted,” “Exercised,” “Expired,” and “Forfeited” reflects the impact of this adjustment, as applicable, regardless of the date of the transaction during 2017. “Other Separation adjustment” reflects the remaining adjustment to produce the Stock Options outstanding at December 31, 2017.
Weighted average assumptions used to determine the fair value of Stock Options issued
The following table presents the weighted average assumptions, with the exception of risk-free rate, which is expressed as a range, that the model uses to determine the fair value of unexercised Stock Options that MetLife, Inc. has granted:
 
 
Years Ended December 31,
 
 
2017
 
2016
 
2015
Dividend yield
 
3.05%
 
3.90%
 
2.72%
Risk-free rate of return
 
0.94% - 3.22%
 
0.62% - 2.85%
 
0.20% - 3.04%
Expected volatility
 
34.19%
 
33.58%
 
32.56%
Exercise multiple
 
1.43
 
1.43
 
1.44
Post-vesting termination rate
 
2.94%
 
2.58%
 
2.73%
Contractual term (years)
 
10
 
10
 
10
Expected life (years)
 
6
 
7
 
7
Weighted average exercise price of stock options granted
 
$46.85
 
$34.33
 
$45.91
Weighted average fair value of stock options granted
 
$12.36
 
$8.27
 
$11.87
Performance Share and Restricted Stock Unit Activity
The following table presents a summary of Performance Share and Restricted Stock Unit activity:
 
Performance Shares
 
Restricted Stock Units
 
Shares
 
Weighted
Average
Fair Value (1)
 
Units
 
Weighted
Average
Fair Value (1)
Outstanding at January 1, 2017
3,817,100

 
$
49.88

 
3,422,013

 
$
39.08

Granted (2)
1,225,333

 
$
45.60

 
1,445,238

 
$
42.45

Forfeited (2)
(270,292
)
 
$
42.94

 
(251,216
)
 
$
35.64

Payable (2) (3)
(1,192,734
)
 
$
44.84

 
(1,720,168
)
 
$
36.81

Other Separation adjustment (2)
454,353

 
$
42.34

 
408,510

 
$
37.07

Outstanding at December 31, 2017
4,033,760

 
$
46.02

 
3,304,377

 
$
37.17

Vested and expected to vest at December 31, 2017
3,971,002

 
$
46.02

 
3,246,476

 
$
37.14

__________________
(1)
Values for shares outstanding at January 1, 2017, represent weighted average number of shares multiplied by the fair value per share at December 31, 2016. Otherwise, all values represent weighted average of number of shares multiplied by the fair value per share at December 31, 2017. Fair value per share of Restricted Stock Units on December 31, 2017 was equal to Grant Date fair value per share.
(2)
For Performance Shares, Restricted Stock Units, and Deferred Shares outstanding as of August 4, 2017, MetLife, Inc. increased the number of units by an adjustment ratio to maintain the intrinsic value of the award or Deferred Shares pursuant to the anti-dilution provisions of the 2015 Stock Plan and the 2005 Stock Plan as a result of the Separation. MetLife, Inc. determined the adjustment ratio by dividing the $53.92 closing price of MetLife, Inc. common stock on August 4, 2017 by the $48.17 opening price of MetLife, Inc. common stock on August 7, 2017, the next trading day. Each of “Granted,” “Forfeited,” and “Payable” reflects the impact of this adjustment, as applicable, regardless of the date of the transaction during 2017. “Other Separation adjustment” reflects the remaining adjustment to produce the Performance Shares and Restricted Stock Units outstanding at December 31, 2017.
(3)
Includes both Shares paid and Deferred Shares for later payment.
Liability Award Unit Activity
The following table presents a summary of Liability Awards activity:
 
Unit
Options
 
Performance
Units
 
Restricted
Units
Outstanding at January 1, 2017
855,897

 
615,356

 
763,723

Granted (1)
24,175

 
238,487

 
375,414

Exercised (1)
(200,687
)
 
—

 
—

Forfeited (1)
(100,439
)
 
(53,499
)
 
(82,940
)
Paid (1)
—

 
(185,178
)
 
(368,049
)
Other Separation adjustment (1)
102,066

 
73,063

 
90,928

Outstanding at December 31, 2017
681,012

 
688,229

 
779,076

Vested and expected to vest at December 31, 2017
612,911

 
619,406

 
701,168


__________________
(1)
For Unit Options, Performance Units, and Restricted Units outstanding as of August 4, 2017, MetLife, Inc. increased the number of units, and for Units Options lowered the exercise price by an adjustment ratio to maintain the intrinsic value of the award pursuant to the anti-dilution provisions of the 2015 Stock Plan and the 2005 Stock Plan as a result of the Separation. MetLife, Inc. determined the adjustment ratio by dividing the $53.92 closing price of MetLife, Inc. common stock on August 4, 2017 by the $48.17 opening price of MetLife, Inc. common stock on August 7, 2017, the next trading day. Each of “Granted,” “Exercised,” “Forfeited,” and “Paid” reflects the impact of this adjustment, as applicable, regardless of the date of the transaction during 2017. “Other Separation adjustment” reflects the remaining adjustment to produce the Unit Options, Performance Units, and Restricted Units outstanding at December 31, 2017.
Schedules of statutory net income, capital and surplus and reserve strengthening by subsidiary
Statutory net income (loss) was as follows:
 
 
 
 
Years Ended December 31,
Company
 
State of Domicile
 
2017
 
2016
 
2015
 
 
 
 
(In millions)
Metropolitan Life Insurance Company (1)
 
New York
 
$
1,982

 
$
3,444

 
$
3,703

American Life Insurance Company
 
Delaware
 
$
3,077

 
$
341

 
$
335

Brighthouse Life Insurance Company (2)
 
Delaware
 
N/A

 
$
1,186

 
$
(1,022
)
Metropolitan Property and Casualty Insurance Company
 
Rhode Island
 
$
197

 
$
171

 
$
204

Metropolitan Tower Life Insurance Company
 
Delaware
 
$
74

 
$
8

 
$
(42
)
New England Life Insurance Company (2)
 
Massachusetts
 
N/A

 
$
109

 
$
157

General American Life Insurance Company
 
Missouri
 
$
90

 
$
(2
)
 
$
204

Other (3)
 
Various
 
$
11

 
$
(70
)
 
$
20


__________________
(1)
In December 2016, MLIC transferred all of the issued and outstanding shares of the common stock of each of New England Life Insurance Company (“NELICO”) and General American Life Insurance Company (“GALIC”) to MetLife, Inc., in the form of a non-cash extraordinary dividend.
(2)
Effective April 28, 2017 in connection with the Separation, MetLife, Inc. contributed all of the issued and outstanding shares of common stock of each of Brighthouse Insurance and NELICO to Brighthouse Holdings, LLC. As a result of the Separation, Brighthouse Insurance and NELICO ceased to be subsidiaries of MetLife, Inc.
(3)
Effective April 28, 2017 in connection with the Separation, MetLife, Inc. contributed all of the issued and outstanding shares of Brighthouse Life Insurance Company of NY (“Brighthouse NY”) to Brighthouse Holdings, LLC. As a result of the Separation, Brighthouse NY ceased to be a subsidiary of MetLife, Inc. For the years ended December 31, 2016 and 2015, statutory net income (loss) of Brighthouse NY was ($87) million and $17 million, respectively.
Statutory capital and surplus was as follows at:
 
 
December 31,
Company
 
2017
 
2016
 
 
(In millions)
Metropolitan Life Insurance Company (1)
 
$
10,384

 
$
11,195

American Life Insurance Company
 
$
6,548

 
$
5,895

Brighthouse Life Insurance Company (2)
 
N/A

 
$
4,374

Metropolitan Property and Casualty Insurance Company
 
$
2,266

 
$
2,271

Metropolitan Tower Life Insurance Company
 
$
733

 
$
669

New England Life Insurance Company (2)
 
N/A

 
$
455

General American Life Insurance Company
 
$
988

 
$
923

Other (3)
 
$
100

 
$
303


__________________
(1)
In December 2016, MLIC transferred all of the issued and outstanding shares of the common stock of each of NELICO and GALIC to MetLife, Inc. in the form of a non-cash extraordinary dividend.
(2)
Effective April 28, 2017 in connection with the Separation, MetLife, Inc. contributed all of the issued and outstanding shares of common stock of each of Brighthouse Insurance and NELICO to Brighthouse Holdings, LLC. As a result of the Separation, Brighthouse Insurance and NELICO ceased to be subsidiaries of MetLife, Inc.
(3)
Effective April 28, 2017 in connection with the Separation, MetLife, Inc. contributed all of the issued and outstanding shares of Brighthouse NY to Brighthouse Holdings, LLC. As a result of the Separation, Brighthouse NY ceased to be a subsidiary of MetLife, Inc. At December 31, 2016, Brighthouse NY statutory capital and surplus was $196 million.
Dividend Payment Restrictions
The table below sets forth the dividends permitted to be paid by MetLife, Inc.’s primary insurance subsidiaries without insurance regulatory approval and dividends paid:
 
 
2018
 
2017
 
 
2016
Company
 
Permitted Without
Approval (1)
 
Paid (2)
 
 
Paid (2)
 
 
(In millions)
 
Metropolitan Life Insurance Company 
 
$
3,075

 
$
2,523

 
 
$
5,740

(3
)
American Life Insurance Company
 
$
—

 
$
2,200

(4)
 
$
—

 
Brighthouse Life Insurance Company (5)
 
N/A

 
$
—

 
 
$
261

 
Metropolitan Property and Casualty Insurance Company
 
$
125

 
$
185

 
 
$
228

 
Metropolitan Tower Life Insurance Company
 
$
73

 
$
—

 
 
$
60

 
New England Life Insurance Company (5)
 
N/A

 
$
—

 
 
$
295

(6
)
General American Life Insurance Company
 
$
118

 
$
1

 
 
$
—

 
__________________
(1)
Reflects dividend amounts that may be paid during 2018 without prior regulatory approval. However, because dividend tests may be based on dividends previously paid over rolling 12-month periods, if paid before a specified date during 2018, some or all of such dividends may require regulatory approval.
(2)
Reflects all amounts paid, including those requiring regulatory approval.
(3)
In 2016, MLIC paid an ordinary cash dividend to MetLife, Inc. in the amount of $3.6 billion. In addition, in December 2016, MLIC distributed all of the issued and outstanding shares of common stock of each of NELICO and GALIC to MetLife, Inc. in the form of a non-cash extraordinary dividend in the amount of $981 million and $1.2 billion, respectively, as calculated on a statutory basis.
(4)
Represents an extraordinary dividend.
(5)
Effective April 28, 2017 in connection with the Separation, MetLife, Inc. contributed all of the issued and outstanding shares of common stock of each of Brighthouse Insurance and NELICO to Brighthouse Holdings, LLC. As a result of the Separation, Brighthouse Insurance and NELICO ceased to be subsidiaries of MetLife, Inc. See Note 3 for other Brighthouse dividend transactions prior to the Separation.
(6)
Represents an extraordinary dividend paid by NELICO in 2016 to MetLife, Inc.
Components of Accumulated Other Comprehensive Income (Loss)
Information regarding changes in the balances of each component of AOCI attributable to MetLife, Inc., was as follows:
 
Unrealized
Investment Gains
(Losses), Net of
Related Offsets (1)
 
Unrealized Gains
(Losses) on
Derivatives
 
Foreign
Currency
Translation
Adjustments
 
Defined
Benefit
Plans
Adjustment
 
Total
 
(In millions)
Balance at December 31, 2014
$
15,224

 
$
1,076

 
$
(3,303
)
 
$
(2,283
)
 
$
10,714

OCI before reclassifications
(7,224
)
 
(19
)
 
(1,646
)
 
125

 
(8,764
)
Deferred income tax benefit (expense)
2,456

 
6

 
(1
)
 
(43
)
 
2,418

AOCI before reclassifications, net of income tax
10,456

 
1,063

 
(4,950
)
 
(2,201
)
 
4,368

Amounts reclassified from AOCI
(223
)
 
608

 
—

 
229

 
614

Deferred income tax benefit (expense)
78

 
(213
)
 
—

 
(80
)
 
(215
)
Amounts reclassified from AOCI, net of income tax
(145
)
 
395

 
—

 
149

 
399

Balance at December 31, 2015
10,311

 
1,458

 
(4,950
)
 
(2,052
)
 
4,767

OCI before reclassifications
800

 
344

 
(476
)
 
(62
)
 
606

Deferred income tax benefit (expense)
(338
)
 
(100
)
 
114

 
24

 
(300
)
AOCI before reclassifications, net of income tax
10,773

 
1,702

 
(5,312
)
 
(2,090
)
 
5,073

Amounts reclassified from AOCI
21

 
229

 
—

 
193

 
443

Deferred income tax benefit (expense)
(9
)
 
(66
)
 
—

 
(75
)
 
(150
)
Amounts reclassified from AOCI, net of income tax
12

 
163

 
—

 
118

 
293

Balance at December 31, 2016
10,785

 
1,865

 
(5,312
)
 
(1,972
)
 
5,366

OCI before reclassifications
5,392

 
(140
)
 
765

 
(23
)
 
5,994

Deferred income tax benefit (expense)
(1,732
)
 
47

 
125

 
8

 
(1,552
)
AOCI before reclassifications, net of income tax
14,445

 
1,772

 
(4,422
)
 
(1,987
)
 
9,808

Amounts reclassified from AOCI
(289
)
 
(1,025
)
 
—

 
167

 
(1,147
)
Deferred income tax benefit (expense)
87

 
356

 
—

 
(43
)
 
400

Amounts reclassified from AOCI, net of income tax
(202
)
 
(669
)
 
—

 
124

 
(747
)
Disposal of subsidiary (2)
(2,286
)
 
(305
)
 
51

 
28

 
(2,512
)
Deferred income tax benefit (expense)
800

 
107

 
(19
)
 
(10
)
 
878

Disposal of subsidiary, net of income tax
(1,486
)
 
(198
)
 
32

 
18

 
(1,634
)
Balance at December 31, 2017
$
12,757

 
$
905

 
$
(4,390
)
 
$
(1,845
)
 
$
7,427

__________________
(1)
See Note 8 for information on offsets to investments related to future policy benefits, DAC, VOBA and DSI, and the policyholder dividend obligation.
(2)
See Note 3.
Reclassification out of Accumulated Other Comprehensive Income (Loss)
Information regarding amounts reclassified out of each component of AOCI was as follows:
AOCI Components
 
Amounts Reclassified from AOCI
 
Consolidated Statements of
Operations Locations
 
 
Years Ended December 31,
 
 
 
 
2017
 
2016
 
2015
 
 
 
 
(In millions)
 
 
Net unrealized investment gains (losses):
 
 
 
 
 
 
 
 
Net unrealized investment gains (losses)
 
$
404

 
$
78

 
$
263

 
Net investment gains (losses)
Net unrealized investment gains (losses)
 
20

 
39

 
35

 
Net investment income
Net unrealized investment gains (losses)
 
(49
)
 
(37
)
 
56

 
Net derivative gains (losses)
Net unrealized investment gains (losses)
 
(86
)
 
(101
)
 
(131
)
 
Discontinued operations
Net unrealized investment gains (losses), before income tax
 
289

 
(21
)
 
223

 
 
Income tax (expense) benefit
 
(87
)
 
9

 
(78
)
 
 
Net unrealized investment gains (losses), net of income tax
 
202

 
(12
)
 
145

 
 
Unrealized gains (losses) on derivatives - cash flow hedges:
 
 
 
 
 
 
 
 
Interest rate swaps
 
24

 
56

 
84

 
Net derivative gains (losses)
Interest rate swaps
 
16

 
12

 
11

 
Net investment income
Interest rate swaps
 
2

 
36

 
2

 
Discontinued operations
Interest rate forwards
 
(11
)
 
(1
)
 
4

 
Net derivative gains (losses)
Interest rate forwards
 
2

 
4

 
3

 
Net investment income
Interest rate forwards
 
1

 
1

 
2

 
Other expenses
Interest rate forwards
 
3

 
4

 
4

 
Discontinued operations
Foreign currency swaps
 
974

 
(350
)
 
(720
)
 
Net derivative gains (losses)
Foreign currency swaps
 
—

 
(2
)
 
(1
)
 
Net investment income
Foreign currency swaps
 
2

 
2

 
1

 
Other expenses
Foreign currency swaps
 
11

 
5

 
—

 
Discontinued operations
Credit forwards
 
1

 
3

 
1

 
Net derivative gains (losses)
Credit forwards
 
—

 
1

 
—

 
Net investment income
Credit forwards
 
—

 
—

 
1

 
Discontinued operations
Gains (losses) on cash flow hedges, before income tax
 
1,025

 
(229
)
 
(608
)
 
 
Income tax (expense) benefit
 
(356
)
 
66

 
213

 
 
Gains (losses) on cash flow hedges, net of income tax
 
669

 
(163
)
 
(395
)
 
 
Defined benefit plans adjustment: (1)
 
 
 
 
 
 
 
 
Amortization of net actuarial gains (losses)
 
(190
)
 
(199
)
 
(231
)
 
 
Amortization of prior service (costs) credit
 
23

 
6

 
6

 
 
Discontinued operations
 
—

 
—

 
(4
)
 
 
Amortization of defined benefit plan items, before income tax
 
(167
)
 
(193
)
 
(229
)
 
 
Income tax (expense) benefit
 
43

 
75

 
80

 
 
Amortization of defined benefit plan items, net of income tax
 
(124
)
 
(118
)
 
(149
)
 
 
Total reclassifications, net of income tax
 
$
747

 
$
(293
)
 
$
(399
)
 
 
__________________
(1)
These AOCI components are included in the computation of net periodic benefit costs. See Note 17.